UIA
PFE icon

UBP Investment Advisors’s Pfizer PFE Stock Holding History

UBP Investment Advisors’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$830K Hold
18,981
– – 0.43% 39
2022
Q2 		$1M Buy
+18,981
New +$967K 0.4% 34

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBP Investment Advisors's PFE Position: Q3 2022 in Review

UBP Investment Advisors held its Pfizer (PFE) position steady in Q3 2022 at 18,981 shares worth $830K. The position accounts for 0.43% of the portfolio, ranked #39.

UBP Investment Advisors first reported a position in PFE in Q2 2022 and has held it in 2 quarters since. The position peaked at $1M in Q2 2022. 3,085 funds tracked by Wall St. Rank hold PFE as of Q3 2022.

  • UBP Investment Advisors held 18,981 shares of Pfizer worth $830K as of Q3 2022.
  • UBP Investment Advisors left its Pfizer share count unchanged in Q3 2022.
  • Pfizer made up 0.43% of UBP Investment Advisors's portfolio in Q3 2022, its #39 holding.
  • UBP Investment Advisors first reported a position in Pfizer in Q2 2022 and has held it in 2 quarters since.
  • UBP Investment Advisors's Pfizer position peaked at $1M in Q2 2022.
  • 3,085 funds tracked by Wall St. Rank held Pfizer as of Q3 2022.

Based on UBP Investment Advisors's 13F filing for Q3 2022, filed 4 Oct 2022.